Introduction
Infections caused by multidrug-resistant bacteria have declared a substantial threat to public health worldwide. 1 Carbapenems are the most important antibiotics used for the treatment of infections caused by extended-spectrum β-lactamases (ESBLs) and AmpC-producing Gram-negative bacteria. 2 Several mechanisms including the loss of outer membrane proteins and carbapenemase such as KPC, GES, VIM, IMP, GIM, New Delhi metallo-beta-lactamase (NDM), and OXA-types are involved in resistance to carbapenems in Enterobacteriaceae. 3 Carbapenemase-producing bacteria usually cause life-threatening infections and long-time hospitalization in health care settings. 1 NDM-producing K. pneumoniae are broadly considered as multidrug-resistant bacteria that have been commonly associated with additional resistance mechanisms such as AmpC, ESBLs, and methylation of 16S rRNA by armA, rmtA, rmtB, and rmtC. 8 Several typing methods have been introduced and developed for epidemiological investigation of K. pneumoniae including enterobacterial repetitive intergenic consensus amplification (ERIC-PCR) and multilocus sequence typing (MLST). 9, 10 MLST is one of the best molecular typing methods for long-term and global epidemiological investigations, and ERIC-PCR is usually used for local outbreaks over a short period of time. 10 In this study, we investigated the molecular epidemiology from NDM-1-producing clones among carbapenem-resistant K. pneumoniae isolates in Kerman hospitals, Iran, and we emphasized on the clonal relatedness of these isolates.
Materials and methods

Bacterial isolates
In this study, 175 nonduplicated isolates of K. pneumoniae were collected from hospitalized patients in four referral hospitals (Shafa, Afzalipoor, Bahonar, and Kashani) during February 2015 to November 2017 in Kerman, Iran. All the isolates were identified as K. pneumoniae by standard microbiological tests. 11 antibiotic susceptibility testing Antibacterial susceptibility test of isolates to cefepime (30 µg) , cefotaxime (30 µg), cefoxitin (30 µg), ceftazidime (30 µg) , ceftizoxime (30 µg), cefpodoxime (10 µg), imipenem (10 µg), meropenem (10 µg), ertapenem (10 µg), gentamicin (10 µg), amikacin (30 µg), ciprofloxacin (5 µg), and norfloxacin (10 µg) (Mast Group Ltd., Bootle, UK) was determined by disk diffusion method on Müller-Hinton agar media (Laboratorios CONDA, Madrid, Spain) according to the Clinical and Laboratory Standards Institute (CLSI). 12 Minimum inhibitory concentration (MIC) of isolates to cefotaxime, cefepime, and imipenem was determined by microbroth dilution method according to CLSI. To determine MIC of colistin and tigecycline by microbroth dilution method, we used the European Committee on Antimicrobial Susceptibility Testing recommendations (http://www.eucast. org/clinical-breakpoints). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as standard strains in antibacterial susceptibility testing.
Detection of esBls, ampc, and carbapenemase-producing isolates
ESBLs and carbapenemase-producing isolates were determined according to CLSI recommendations by combination disk with clavulanate and Carba NP test, respectively. 12 AmpC disk test was used to detect AmpC β-lactamase-producing isolates. 13 genomic Dna extraction
The genomic DNA was extracted using Exgene Clinic SV (GeneAll Biotechnology, Co., Ltd., Seoul, Republic of Korea; Kat: 106-152) according to the manufacturer's guidelines.
Detection of resistance genes by PcR sequencing
Antibiotic resistance genes including ESBLs (bla TEM , bla SHV , bla CTX-M , bla OXA-1 , and bla PER ), caebapenemase (bla KPC , bla GES , bla , bla IMP , bla VIM , bla NDM , bla SPM , bla SIM , bla GIM , and bla AIM ), efflux pump (oxqA/B), 16S rRNA methylase (rmtA, rmtB, rmtC, and armA), and mcr-1 (colistin resistance gene) were detected by PCR. The primers used for amplification of resistance genes are listed in Table 1 . The AmpC β-lactamase genes including bla CMY , bla FOX , bla ACC , bla ACT , bla DHA , bla EBC , and bla CIT were detected by using multiplex PCR as previously described, and furthermore, PCR products were confirmed by sequencing (Bioneer Corporation, Daejeon, Republic of Korea). 29 MlsT of nDM-producing isolates MLST of isolates was performed using seven conserved housekeeping genes (gapA, infB, mdh, pgi, phoE, rpoB, and tonB) according to protocols available at the MLST Pasteur website (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html) for NDM-producing isolates. Products of the above genes in MLST were sequenced by Bioneer, Co. Sequences of each housekeeping gene in both directions were analyzed by Sequence Scanner Software v.2.0 (Applied Biosystems by Thermo Fisher Scientific, Waltham, MA, USA) and assembled by Lasergene 6 software (DNASTAR). The sequence types (STs) of each isolate were determined based on the seven studied loci described at http://bigsdb.pasteur. fr/klebsiella/klebsiella.html.
Molecular typing of bla nDM -positive isolates by eRIc-PcR ERIC-PCR using ERIC2 primer (5′-AAGTAAGT-GACTGGGGTGAGC-3′) was used for molecular typing of NDM-positive isolates. 30 The results of ERIC-PCR were 
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Dissemination of different STs of carbapenem-resistant K. pneumoniae analyzed in http://insilico.ehu.eus/dice_upgma/ using the Dice similarity coefficient. Clusters were defined as DNA patterns sharing ≥80% similarity.
Results
In this study, 175 nonduplicated isolates of K. pneumoniae were recovered from hospitalized patients in four referral hospitals in Kerman, Iran. The isolates were collected from different specimens including burning wounds 9 (5.1%), urine 126 (72%), blood 21 (12%), bronchoalveolar lavage 16 (9.1%), and cerebrospinal fluid 3 (1.7%).
antimicrobial susceptibility testing 
Molecular typing of nDM-producing isolates
In this study, we described the first NDM-producing K. pneumoniae isolates belonging to the ST268 (n=14), which was the major ST. The other STs were as follows: ST43 (n=9), ST340 (n=7), ST392 (n=5), ST147 (n=1), and ST16 (n=1).
According to the eBURST results, ST268 is triple-locus variants of ST16 reporting NDM-producing K. pneumoniae previously. In this study, in comparison with other STs, most isolates of K. pneumoniae ST268 carrying rmtC gene were associated with neonatal intensive care unit (NICU), whereas one of K. pneumoniae ST43 isolate coproducing armA and bla NDM genes was associated with surgical unit (Table 3) . Table 3 showed distribution and genetic characterization of 37 NDM-producing K. pneumoniae strains. ERIC-PCR findings showed that the 37 NDM-producing strains were divided into 7 clusters A to G (11 strains in clusters A, 2 strains in clusters B, E, G, 7 strains in cluster C, 5 strains in cluster D, 4 strains in cluster F, and 3 strains were selected to represent sporadic strains) ( Figure 1 ). ST43 was divided into three clusters (A, C, E), ST268 divided into four clusters (C, D, E, F), ST340 divided into four clusters (A, C, F, G), ST392 divided into three clusters (A, B, G), ST16 was subdivided into one cluster, and ST147 showed as one singleton ( Figure  1 and Table 3 ).
Discussion
During the past decades, carbapenem resistance among K. pneumoniae is typically caused by the emergence of transmissible carbapenemases, such as bla KPC and bla NDM . 5 NDM specially comprises of the most rapidly growing group of metallo-beta-lactamases. 5 They have been increasingly detected in different countries, suggesting a worldwide dissemination. 1 Here, we reported the distribution of nosocomial infections caused by NDM-producing K. pneumoniae, especially in NICU from four referral hospitals in Kerman, Iran.
According to the previous studies, our findings showed that the most effective antibiotics against isolates were colistin and tigecycline. 31, 32 However, most isolates exhib- 
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Dissemination of different STs of carbapenem-resistant K. pneumoniae ST43  ST43  ST43  ST43  ST43  ST392  ST392  ST340  ST392  ST16  ST268  ST268  ST43  ST268  ST268   ST268  ST268  ST268  ST268  ST268  ST268  ST43  ST268  ST268  ST268  ST340  ST392  ST340  ST268  ST147   ST340 ited a high resistance level to other antimicrobial agents including extended spectrum cephalosporins, carbapenems, quinolones, and aminoglycosides. Similar to our findings, in the study in Egypt, all carbapenem-resistant K. pneumoniae isolates were sensitive to colistin and tigecycline. 32 In this study, eleven (17.46%) isolates indicated positive results for AmpC disk test. In our study, non-AmpC-producing isolates might be associated with other resistance mechanisms. Shi et al reported that cefoxitin resistance could be related to the change of cellular permeability to antibiotics, resulting from the loss or deficiency of outer membrane proteins. 33, 34 In our hospital settings, we found the emergence and establishment of NDM-producing K. pneumoniae along with rmtC and armA. Sporadic dissemination of NDM-1 in Iran was first described in 2013, which was resistant to the majority of antibiotics except for colistin. 1 In the current findings, we detected four clinical isolates being resistant to colistin, although one of them only harbored bla NDM-1 gene. This study also focused on epidemiological investigation of MLST and ERIC-PCR in the NDM-positive K. pneumoniae. To the best of our knowledge, the obvious report of the ST prevalence has not been yet accounted for NDM-producing K. pneumoniae in Iran. However, we reported the prevalence of different STs of NDM-producing K. pneumoniae among hospitalized patients during 3 years from March 2015 to November 2017 in Kerman.
According to this study, NDM-producing STs including ST16, ST147, and ST340 were found in India and Korea. 35, 36 On the contrary, ST147 was recently observed in NDM-positive K. pneumoniae in Iraq. 37 Our data showed a dissemination of a novel ST namely 268, which has not been reported in NDM-1-producing K. pneumoniae, during February 2016 to November 2017. The ST268 has been established as a major threat to NICUs from two referral hospitals after detecting the following STs including ST43, ST340, ST392, and ST14.
In general, the epidemiological trend of NDM-producing isolates in our hospital might be divided into three stages. From March 2015 to December 2015, the following STs ST43, ST340, ST392, and ST147 were found. From 
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Dissemination of different STs of carbapenem-resistant K. pneumoniae the beginning of February 2016 up till November 2017, the ST268 has been mainly investigated. Based on these findings, we supposed the ST268 was a successful clone to have recently been established in our hospital settings in 2017. This ST has been found in hypermucoviscous K. pneumonia, which was associated with invasive liver abscess syndrome in eastern Asia. 38 On the contrary, ST268 was recognized in capsule serotype K20 K. pneumoniae isolates, relating to primary meningitis in Taiwan. 39 Furthermore, these isolates were significantly associated with the virulence factors such as rmpA, rmpA2, and aerobactin. 39 Importantly, nine of ten rmtC-positive isolates in our current study belonged to K. pneumoniae, representing ST268, which often exhibited the most predominant ST of carbapenem-resistant K. pneumoniae isolates in NICU. Coproduction of 16S rRNA methylase resistance genes (rmtC, armA) among carbapenem-resistant K. pneumoniae with ST14 and ST340 was reported by Poirel et al. 40 In our findings, we observed another major ST, namely ST43, identified during 2015. This ST was able to carry virulence factors causing bacteremia. 41 In this study, most isolates belonging to ST43 have been detected from blood samples (Table 3) . Recently, ST147 has been associated with bla CMY-4 gene and bla OXA-48 described in Tunisia. 42 In our study, ST147 was associated with bla NDM , bla CTX-M , and bla SHV , although this ST has been recognized as a serious threat to public health worldwide.
36 ST16 was the other type represented by one isolate from Afzalipoor Hospital. In this study, ST16 has been associated with bla NDM , bla CTX-M , and bla SHV . This ST has been recently reported in Italy, coproducing NDM-1 and OXA-232, recovering from blood and urine samples of a hospitalized patient with urosepsis. 43 However, Lester et al 34 and Hammerum et al 44 in New Zealand and Denmark showed that K. pneumoniae ST16 was recognized at several occasions, disseminating ESBLs and NDM-5 carbapenemase genes. Our findings showed that ST340 has different ERIC-PCR patterns, that is a single-locus variant of ST11, which was found in Sweden and the UK. 45, 46 Additionally, NDMproducing isolates from ST340 detected in March 2015 were compared with isolates collected with the same ST in November 2017 to check for ERIC-PCR profile variations within NDM-positive K. pneumoniae. As shown in Figure 1 , ERIC-PCR pattern from ST340 displayed identical ERIC-PCR profiles among NDM-producing isolates with the other STs (43, 268, 392, and 16) in different clusters. Similar to this study, Richter et al in Italy showed that no ERIC-PCR profile variation was found between carbapenemase-producing K. pneumoniae strains from STs 258 and 37. 47 Lascols et al in India showed a diverse range of clones harboring carbapenemase-producing K. pneumoniae strains representing STs 147 and 340. 36, 40, 48, 49 The prevalence of bla NDM-1 is frequently associated with promiscuous plasmids related to a broad host range of clinical variants harboring bla NDM-1 , hence our findings hypothesized that nosocomial acquisition of bla NDM by both outward sources including patients who have traveled to Iran specially neighboring countries and also have acquired a broad spectrum of different resistance genes. 48 We detected K. pneumoniae ST392, which has been previously associated with the dissemination of bla NDM-1 , bla KPC , and bla OXA-48 genes. 50, 51 However, in this study, ST392 was detected among bla NDM -and bla OXApositive isolates, recovering from one hospital with different ERIC-PCR patterns. In this study, some STs were observed to have different ERIC-PCR pattern types; therefore, our molecular typing results revealed that ERIC-PCR and MLST provided measures of genetic diversity, while they were not similar methods. These findings showed that ERIC-PCR displayed pattern discriminations for same STs; however, ERIC-PCR has provided a potential molecular typing method to distinguish greater ranges of genetic changes among NDM-positive K. pneumoniae in our hospital settings. 52 In this study, up to November 2017, 37 patients with at least one NDM-positive K. pneumoniae isolates were identified. Most isolates were recovered at Afzalipoor Hospital from NICU (Table 3) . Interestingly, the most NDM-positive K. pneumoniae isolates belonged to the two STs; 268 and 340 displayed various ERIC-PCR patterns within different clusters. On the contrary, in different hospitals, K. pneumoniae isolates with similar STs revealed diverse ERIC-PCR patterns during 2015-2017. It was suggested that these isolates might be affected by coacquisition of some antibiotic resistance plasmids; therefore, it might affect the results of the ERIC-PCR patterns. Moreover, the molecular typing techniques such as ERIC-PCR and pulsed-field gel electrophoresis were used to identify alterations in short-term, while no obvious difference was observed in STs during 3 years, since MSLT is considered to evaluate the alternations in the most conserved genes, showing long-term variations. 52 
Conclusion
In this study, the molecular characterization and epidemiological investigations revealed the dissemination of different clones of NDM-producing K. pneumoniae in our hospital settings. Due to the highly resistant nature of bacterial strains carrying the bla NDM , there are very limited antibiotics to 
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Kiaei et al combat these bacteria. In this study, MLST differentiated the 37 representative NDM-positive K. pneumoniae strains into 7 STs. The STs included ST268 (n=14), ST43 (n=9), ST340 (n=7), ST392 (n=5), and single isolates representing STs 147 and 16. To the best of our knowledge, the clinical isolates of K. pneumoniae representing ST268 have not been reported among NDM-producing K. pneumoniae. Distribution of bla NDM is obviously related to the promiscuity of many plasmids resulting in a wide range of Gram-negative bacteria containing diverse bla NDM harboring plasmids. However, our study suggests that dominant clones (STs 43 and 268) have had a potential role to monitor and continue a long-term survival of bla NDM-1 dissemination. In addition, our data highlight that the potential for local and neighboring countries such as Pakistan, India, and Iraq has been reported as the endemic dissemination of bla NDM -producing K. pneumoniae clones and plasmid-mediated resistance. Therefore, dissemination of different clones with bla NDM among carbapenem-resistant K. pneumoniae might have resulted in more frequent opportunities for the emergence of bla NDM -positive among other Gram-negative bacteria and it highlighted the need to ongoing epidemiological surveillance and comprehensive infection control guidelines. We also suggested the intrinsic genetic factors, causing a spread and establishment of ST268, as a new NDM-producing K. pneumoniae clone identified to increase our knowledge about it.
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